Report Detail

Pharma & Healthcare Global Betahistine Market Research Report 2021

  • RnM4302460
  • |
  • 07 April, 2021
  • |
  • Global
  • |
  • 91 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Betahistine Market Overview

  • 1.1 Product Overview and Scope of Betahistine
  • 1.2 Betahistine Segment by Type
    • 1.2.1 Global Betahistine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 8mg
    • 1.2.3 25mg
    • 1.2.4 Others
  • 1.3 Betahistine Segment by Application
    • 1.3.1 Betahistine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Cerebral Thrombosis
    • 1.3.3 Cerebral Embolism
    • 1.3.4 Others
  • 1.4 Global Betahistine Market Size Estimates and Forecasts
    • 1.4.1 Global Betahistine Revenue 2016-2027
    • 1.4.2 Global Betahistine Sales 2016-2027
    • 1.4.3 Betahistine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Betahistine Market Competition by Manufacturers

  • 2.1 Global Betahistine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Betahistine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Betahistine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Betahistine Manufacturing Sites, Area Served, Product Type
  • 2.5 Betahistine Market Competitive Situation and Trends
    • 2.5.1 Betahistine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Betahistine Players Market Share by Revenue
    • 2.5.3 Global Betahistine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Betahistine Retrospective Market Scenario by Region

  • 3.1 Global Betahistine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Betahistine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Betahistine Market Facts & Figures by Country
    • 3.3.1 North America Betahistine Sales by Country
    • 3.3.2 North America Betahistine Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Betahistine Market Facts & Figures by Country
    • 3.4.1 Europe Betahistine Sales by Country
    • 3.4.2 Europe Betahistine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Betahistine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Betahistine Sales by Region
    • 3.5.2 Asia Pacific Betahistine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Betahistine Market Facts & Figures by Country
    • 3.6.1 Latin America Betahistine Sales by Country
    • 3.6.2 Latin America Betahistine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Betahistine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Betahistine Sales by Country
    • 3.7.2 Middle East and Africa Betahistine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Betahistine Historic Market Analysis by Type

  • 4.1 Global Betahistine Sales Market Share by Type (2016-2021)
  • 4.2 Global Betahistine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Betahistine Price by Type (2016-2021)

5 Global Betahistine Historic Market Analysis by Application

  • 5.1 Global Betahistine Sales Market Share by Application (2016-2021)
  • 5.2 Global Betahistine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Betahistine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 TOWA PHARMACEUTICAL CO., LTD
    • 6.1.1 TOWA PHARMACEUTICAL CO., LTD Corporation Information
    • 6.1.2 TOWA PHARMACEUTICAL CO., LTD Description and Business Overview
    • 6.1.3 TOWA PHARMACEUTICAL CO., LTD Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 TOWA PHARMACEUTICAL CO., LTD Product Portfolio
    • 6.1.5 TOWA PHARMACEUTICAL CO., LTD Recent Developments/Updates
  • 6.2 Nichi-Iko Pharmaceutical
    • 6.2.1 Nichi-Iko Pharmaceutical Corporation Information
    • 6.2.2 Nichi-Iko Pharmaceutical Description and Business Overview
    • 6.2.3 Nichi-Iko Pharmaceutical Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Nichi-Iko Pharmaceutical Product Portfolio
    • 6.2.5 Nichi-Iko Pharmaceutical Recent Developments/Updates
  • 6.3 Takeda Pharmaceutical Company Limited
    • 6.3.1 Takeda Pharmaceutical Company Limited Corporation Information
    • 6.3.2 Takeda Pharmaceutical Company Limited Description and Business Overview
    • 6.3.3 Takeda Pharmaceutical Company Limited Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Takeda Pharmaceutical Company Limited Product Portfolio
    • 6.3.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  • 6.4 EA Pharma Co., Ltd.
    • 6.4.1 EA Pharma Co., Ltd. Corporation Information
    • 6.4.2 EA Pharma Co., Ltd. Description and Business Overview
    • 6.4.3 EA Pharma Co., Ltd. Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 EA Pharma Co., Ltd. Product Portfolio
    • 6.4.5 EA Pharma Co., Ltd. Recent Developments/Updates
  • 6.5 Disphar International B.V.
    • 6.5.1 Disphar International B.V. Corporation Information
    • 6.5.2 Disphar International B.V. Description and Business Overview
    • 6.5.3 Disphar International B.V. Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Disphar International B.V. Product Portfolio
    • 6.5.5 Disphar International B.V. Recent Developments/Updates
  • 6.6 HENNIG ARZNEIMITTEL GmbH & Co. KG
    • 6.6.1 HENNIG ARZNEIMITTEL GmbH & Co. KG Corporation Information
    • 6.6.2 HENNIG ARZNEIMITTEL GmbH & Co. KG Description and Business Overview
    • 6.6.3 HENNIG ARZNEIMITTEL GmbH & Co. KG Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 HENNIG ARZNEIMITTEL GmbH & Co. KG Product Portfolio
    • 6.6.5 HENNIG ARZNEIMITTEL GmbH & Co. KG Recent Developments/Updates
  • 6.7 DOC Generici
    • 6.6.1 DOC Generici Corporation Information
    • 6.6.2 DOC Generici Description and Business Overview
    • 6.6.3 DOC Generici Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 DOC Generici Product Portfolio
    • 6.7.5 DOC Generici Recent Developments/Updates
  • 6.8 Ciclum Farma Unipessoal
    • 6.8.1 Ciclum Farma Unipessoal Corporation Information
    • 6.8.2 Ciclum Farma Unipessoal Description and Business Overview
    • 6.8.3 Ciclum Farma Unipessoal Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Ciclum Farma Unipessoal Product Portfolio
    • 6.8.5 Ciclum Farma Unipessoal Recent Developments/Updates
  • 6.9 Mylan
    • 6.9.1 Mylan Corporation Information
    • 6.9.2 Mylan Description and Business Overview
    • 6.9.3 Mylan Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Mylan Product Portfolio
    • 6.9.5 Mylan Recent Developments/Updates
  • 6.10 Orion Corporation
    • 6.10.1 Orion Corporation Corporation Information
    • 6.10.2 Orion Corporation Description and Business Overview
    • 6.10.3 Orion Corporation Betahistine Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Orion Corporation Product Portfolio
    • 6.10.5 Orion Corporation Recent Developments/Updates

7 Betahistine Manufacturing Cost Analysis

  • 7.1 Betahistine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Betahistine
  • 7.4 Betahistine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Betahistine Distributors List
  • 8.3 Betahistine Customers

9 Betahistine Market Dynamics

  • 9.1 Betahistine Industry Trends
  • 9.2 Betahistine Growth Drivers
  • 9.3 Betahistine Market Challenges
  • 9.4 Betahistine Market Restraints

10 Global Market Forecast

  • 10.1 Betahistine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Betahistine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Betahistine by Type (2022-2027)
  • 10.2 Betahistine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Betahistine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Betahistine by Application (2022-2027)
  • 10.3 Betahistine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Betahistine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Betahistine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    8mg
    25mg
    Others

    Segment by Application
    Cerebral Thrombosis
    Cerebral Embolism
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    TOWA PHARMACEUTICAL CO., LTD
    Nichi-Iko Pharmaceutical
    Takeda Pharmaceutical Company Limited
    EA Pharma Co., Ltd.
    Disphar International B.V.
    HENNIG ARZNEIMITTEL GmbH & Co. KG
    DOC Generici
    Ciclum Farma Unipessoal
    Mylan
    Orion Corporation


    Summary:
    Get latest Market Research Reports on Betahistine. Industry analysis & Market Report on Betahistine is a syndicated market report, published as Global Betahistine Market Research Report 2021. It is complete Research Study and Industry Analysis of Betahistine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,098.38
    3,147.58
    4,196.77
    2,420.15
    3,630.23
    4,840.31
    315,592.50
    473,388.75
    631,185.00
    216,543.87
    324,815.81
    433,087.74
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report